| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.94B | +14.9% |
| Cost of Revenue | $151.6M | +23.8% |
| Gross Profit | $1.78B | +14.2% |
| R&D Expense | $322.9M | -40.2% |
| Operating Income | $979.7M | +76.2% |
| Interest Expense | $32.4M | +74.2% |
| Pre-tax Income | $950.6M | +60.1% |
| Income Tax | $223.3M | +89.1% |
| Net Income | $727.3M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $961.2M | +7.4% |
| Short-term Investments | $1.88B | +81.2% |
| Accounts Receivable | $220.4M | +10.9% |
| Inventory | $102.0M | +8.7% |
| Current Assets | $3.38B | +45.5% |
| Total Assets | $6.04B | +16.9% |
| Current Liabilities | $343.2M | +12.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $802.5M | +34.2% |
| Capital Expenditures | $138.8M | +14.9% |
| Investing Cash Flow | -$811.5M | -66.7% |
| Financing Cash Flow | $75.4M | +68.3% |
| Free Cash Flow | $663.7M | +39.0% |
| +52.9% |
| EPS (Basic) | $15.98 | +50.8% |
| EPS (Diluted) | $15.00 | +49.1% |
| Total Liabilities |
| $1.25B |
| +3.1% |
| Stockholders' Equity | $4.80B | +21.2% |